SCHEMBL13329921

SCHEMBL13329921

CCC(CC)N1CCN(c2cnc(-c3nc(N4CC/C(=N/C(=O)c5[nH]c(C)c(Cl)c5Cl)[C@@H](C)C4)sc3C(=O)O)cn2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10211743 0.82 — —
SCHEMBL13330063 0.80 — —
SCHEMBL10214978 0.79 — —
SCHEMBL10211734 0.79 — —
SCHEMBL10214974 0.75 — —
SCHEMBL13330004 0.74 ALDH1A1 (0.39) —
SCHEMBL10211792 0.73 — —
SCHEMBL10212732 0.73 — —
SCHEMBL10214330 0.73 — —
SCHEMBL10211731 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010067123-A1 2- (PIPERIDIN-1-YL) -4-HETEROCYCLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2010-06-17 — — WO disclosed
Send feedback